久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

  • F2G Receives Second FDA Breakthrough Therapy Designation for Olorofim americanpharmaceuticalreview
    October 29, 2020
    F2G announced the US Food and Drug Administration (FDA) has granted an additional Breakthrough Therapy Designation to its lead first-in-class candidate, olorofim, for the indication of “Treatment of Central Nervous System (CNS) coccidioidomycosis ...
  • F2G Receives Orphan Drug Designation for Olorofim americanpharmaceuticalreview
    March 10, 2020
    F2G announced the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to its lead first-in-class candidate, olorofim (formerly F901318) for treatment of invasive aspergillosis ...
PharmaSources Customer Service